Aonong Bio: Suspected of illegal disclosure of information, was filed by the Securities Regulatory Commission.

Ao Nong Biotechnology announced that on April 22, 2026, the company received a "Notice of Filing" from the China Securities Regulatory Commission. Due to the company's suspected illegal and irregular information disclosure, according to the laws and regulations such as the Securities Law of the People's Republic of China and the Administrative Penalty Law of the People's Republic of China, the China Securities Regulatory Commission has decided to file a case against the company. During the investigation period, the company will actively cooperate with the China Securities Regulatory Commission's investigation and strictly fulfill its information disclosure obligations in accordance with relevant laws, regulations, and regulatory requirements.